SUMMARY Pre-dose and peak serum levels of gentamicin were measured in 82 neonates (25-42 weeks' gestational age), and for comparison in 10 infants and 9 children. Dosage was 2-2 5 mg/kg twice daily for the neonates, and three times daily for infants and children.
Measurement of serum levels of gentamicin has led to improvements in its clinical use (Marks et al., 1971; Riley et al., 1971; Chang et al., 1975) . In young children, however, comprehensive data on the subject are still lacking, and Taylor and Keane (1976) have emphasized that the regimens commonly suggested for children will provide an unacceptably low serum concentration of the drug in many. Fear of toxic effects may explain a reluctance to adopt higher dosages, though it is known that both term neonates and older infants need a higher dose per kg body weight than do adults (McCracken and Eichenwald, 1974) . For preterm neonates data are scarce; excretion of the drug is slower, and a different kinetic may be involved (McCracken et al., 1971; Anderson et al., 1972) . There are no studies relating the serum levels reached during gentamicin therapy with gestational age. Nor has the effect of intrauterine development been considered, i.e. whether the neonates are small or appropriate for gestational age. We here present the results of studies carried out on a group of infants of varying gestational ages.
Materials and methods
182 blood samples were taken from a group of 82 neonates (25-42 weeks of gestation) and for comparison from 10 older infants (1 *5-8 months) and 9 children (2-4 years) hospitalized in our departments. In all cases gentamicin had been indicated for Received 18 March 1977 infection, either suspected or shown as being from gentamicin-sensitive Gram-negative bacteria. The dose was 2-2*5 mg/kg twice daily for the neonates, and three times daily for the others, injected intramuscularly according to the scheme suggested by Nelson and McCracken (1972) . Serum levels were monitored starting from the third day of treatment using capillary blood from heel puncture. Gentamicin serum concentration was measured using the method of Grove and Randall (1955) with Bacillus subtilis as the test bacteria, which can estimate serum concentrations down to 0 -25 ,ug/ml. In all cases both the pre-dose and peak levels were measured; from our studies and from published reports (Mc Cracken and Jones, 1970; Echeverria et al., 1975 ) the latter is reached 30 to 60 minutes after intramuscular injection. The results were analysed by subdividing the neonates into four groups according to gestational age. The newborns designated small-for-gestational age (SGA) were those with a birthweight less than the 10th centile according to the standard of Gairdner and Pearson (1971) The remaining newborns were considered appropriate-for-gestational age (AGA).
None of the subjects showed abnormalities of renal function as indicated by routine measurement of blood urea nitrogen and urine analysis.
Results
In Table 1 the pre-dose levels of gentamicin are given according to gestational age. Each of the 4 groups of infants is further divided into those younger and older than 7 days' postnatal age. There were large differences between the levels found in preterm neonates of the same postnatal age. For comparison results are also given for a group of older infants and a group of 9 children. Table 2 gives the percentage of cases where the pre-dose serum gentamicin exceeded 1 ,.g/ml, this concentration being considered indicative of possible accumulation. In the most premature group this occurred in 66% of all cases, or in 71 % if aged less than 7 days. In the other groups of preterm neonates the incidence of a pre-dose level over 1 tag/ml was between 25 and 29%, while in the group of term neonates it depended on the postnatal age. For the older infants the incidence was 20%, while in the older children the value was never exceeded.
Values at 30 and 60 minutes after injection are given in Table 3 To analyse further the difference observed between neonates we have considered whether the condition of being AGA or SGA may influence the situation (Table 4) . At both 30 and 60 minutes drug levels in the AGA infants tend to be higher than those of the SGA infants. Pre-dose levels of 1 [ig/ml and peak levels of 4 tsg/ml are exceeded in a larger number of AGA infants as shown in Fig. 2 .
Discussion
The serum levels we observed in neonates after intramuscular injection of gentamicin were very variable and showed little relationship between the dose administered and the peak concentration (McCracken and Jones, 1970; Riley et al., 1971;  Gentamicin dosage in preterm and term neonates 885 (Siegel and Oh, 1976) , while SGA infants have, proportionally, a larger extracellular fluid compartment (Cassady, 1970 
